Discovery of candidate serum proteomic and metabolomic biomarkers in ankylosing spondylitis

Molecular and Cellular Proteomics

Volumn 11, Issue 2, 2012, Pages

  Fischer, Roman ^a   Trudgian, David C ^a   Wright, Cynthia ^a   Thomas, Gethin ^c   Bradbury, Linda A ^c   Brown, Matthew A ^c   Bowness, Paul ^b   Kessler, Benedikt M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYCOLECALCIFEROL 26,23 PEROXYLACTONE; AMYLOID P COMPONENT; BIOLOGICAL MARKER; COLECALCIFEROL; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN 1; TRYPSIN; UNCLASSIFIED DRUG; VITAMIN D BINDING PROTEIN;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLITE; METABOLOMICS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; UPREGULATION;

EID: 84863420468     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.013904     Document Type: Article

References (59)

1. Elyan, M., and Khan, M. A. (2006) Diagnosing ankylosing spondylitis. J. Rheumatol. 78, 12-23 (Pubitemid 44360188)
2. Rostom, S., Dougados, M., and Gossec, L. (2010) New tools for diagnosing spondyloarthropathy. Joint Bone Spine 77, 108-114
3. Thomas, G. P., and Brown, M. A. (2010) Genomics of ankylosing spondylitis. Discov. Med. 10, 263-271
4. Dougados, M., and Baeten, D. (2011) Spondyloarthritis. Lancet 377, 2127-2137
5. Thomas, G. P., and Brown, M. A. (2010) Genetics and genomics of ankylosing spondylitis. Immunol. Rev. 233, 162-180
6. Evans, D. M., Spencer, C. C., Pointon, J. J., Su, Z., Harvey, D., Kochan, G., Opperman, U., Dilthey, A., Pirinen, M., Stone, M. A., Appleton, L., Moutsianis, L., Leslie, S., Wordsworth, T., Kenna, T. J., Karaderi, T., Thomas, G. P., Ward, M. M., Weisman, M. H., Farrar, C., Bradbury, L. A., Danoy, P., Inman, R. D., Maksymowych, W., Gladman, D., Rahman, P., Morgan, A., Marzo-Ortega, H., Bowness, P., Gaffney, K., Gaston, J. S., Smith, M., Bruges-Armas, J., Couto, A. R., Sorrentino, R., Paladini, F., Ferreira, M. A., Xu, H., Liu, Y., Jiang, L., Lopez-Larrea, C., Diaz-Pena, R., Lopez- Vazquez, A., Zayats, T., Band, G., Bellenguez, C., Blackburn, H., Blackwell, J. M., Bramon, E., Bumpstead, S. J., Casas, J. P., Corvin, A., Craddock, N., Deloukas, P., Dronov, S., Duncanson, A., Edkins, S., Freeman, C., Gillman, M., Gray, E., Gwilliam, R., Hammond, N., Hunt, S. E., Jankowski, J., Jayakumar, A., Langford, C., Liddle, J., Markus, H. S., Mathew, C. G., McCann, O. T., McCarthy, M. I., Palmer, C. N., Peltonen, L., Plomin, R., Potter, S. C., Rautanen, A., Ravindrarajah, R., Ricketts, M., Samani, N., Sawcer, S. J., Strange, A., Trembath, R. C., Viswanathan, A. C., Waller, M., Weston, P., Whittaker, P., Widaa, S., Wood, N. W., McVean, G., Reveille, J. D., Wordsworth, B. P., Brown, M. A., and Donnelly, P. (2011) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat. Genet. 43, 761-767
7. Harvey, D., Pointon, J. J., Evans, D. M., Karaderi, T., Farrar, C., Appleton, L. H., Sturrock, R. D., Stone, M. A., Oppermann, U., Brown, M. A., and Wordsworth, B. P. (2009) Investigating the genetic association between ERAP1 and ankylosing spondylitis. Hum. Mol. Genet. 18, 4204-4212
8. Karaderi, T., Harvey, D., Farrar, C., Appleton, L. H., Stone, M. A., Sturrock, R. D., Brown, M. A., Wordsworth, P., and Pointon, J. J. (2009) Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series. Rheumatology 48, 386-389
9. Kochan, G., Krojer, T., Harvey, D., Fischer, R., Chen, L., Vollmar, M., von Delft, F., Kavanagh, K. L., Brown, M. A., Bowness, P., Wordsworth, P., Kessler, B. M., and Oppermann, U. (2011) Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc. Natl. Acad. Sci. U.S.A. 108, 7745-7750
10. Nguyen, T. T., Chang, S. C., Evnouchidou, I., York, I. A., Zikos, C., Rock, K. L., Goldberg, A. L., Stratikos, E., and Stern, L. J. (2011) Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat. Struct. Mol. Biol. 18, 604-613
11. van der Heijde, D., Sieper, J., Maksymowych, W. P., Dougados, M., Burgos- Vargas, R., Landewé, R., Rudwaleit, M., and Braun, J. (2011) 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. Ann Rheum. Dis. 70, 905-908
12. Braun, J., and Sieper, J. (2009) Classification criteria for rheumatoid arthritis and ankylosing spondylitis. Clin. Exp. Rheumatol. 27, S68-73
13. Tilleman, K., Van Steendam, K., Cantaert, T., De Keyser, F., Elewaut, D., and Deforce, D. (2008) Synovial detection and autoantibody reactivity of processed citrullinated isoforms of vimentin in inflammatory arthritides. Rheumatology 47, 597-604 (Pubitemid 351619196)
14. Benhamou, M., Gossec, L., and Dougados, M. (2010) Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein. Rheumatology 49, 536-541
15. Chandra, P. E., Sokolove, J., Hipp, B. G., Lindstrom, T. M., Elder, J. T., Reveille, J. D., Eberl, H., Klause, U., and Robinson, W. H. (2011) Novel multiplex technology for diagnostic characterization of rheumatoid arthritis. Arthritis Res. Ther. 13, R102
16. López-Longo, F. J., Rodriguez-Mahou, M., Sánchez- Ramón, S., Estecha, A., Balsera, M., Plaza, R., Fernández-Cruz, E., and Pèrez, L. C. (2006) Anti-cyclic citrullinated peptide versus anti-Sa antibodies in diagnosis of rheumatoid arthritis in an outpatient clinic for connective tissue disease and spondyloarthritis. J. Rheumatol. 33, 1476-1481
17. Wright, C., Sibani, S., Trudgian, D., Fischer, R., Kessler, B., Labaer, J., and Bowness, P. (2010) Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays. Mol. Cell. Proteomics. 2, M9.003841-10
18. Duan, R., Leo, P., Bradbury, L., Brown, M. A., and Thomas, G. (2010) Gene expression profiling reveals a downregulation in immune-associated genes in patients with AS. Ann. Rheum. Dis. 69, 1724-1729
19. Arends, S., van der Veer, E., Groen, H., Houtman, P. M., Jansen, T. L., Leijsma, M. K., Bijzet, J., Limburg, P. C., Kallenberg, C. G., Spoorenberg, A., and Brouwer, E. (2011) Serum MMP-3 Level as a Biomarker for Monitoring and Predicting Response to Etanercept Treatment in Ankylosing Spondylitis. J. Rheumatol. 38, 1644-1650
20. Chang, X., Han, J., Zhao, Y., Yan, X., Sun, S., and Cui, Y. (2010) Increased expression of carbonic anhydrase I in the synovium of patients with ankylosing spondylitis. BMC Musculoskelet. Disord. 11, 279
21. Li, T., Zheng, B., Huang, Z., Lu, H., Lin, Q., Liao, Z., Lin, Z., Zhao, L., Wang, X., and Gu, J. (2010) Over-expression of talin 1 and integrin-linked kinase in PBMCs of patients with ankylosing spondylitis: a proteomic study. Clin. Exp. Rheumatol. 28, 828-835
22. Pedersen, S. J., Sørensen, I. J., Garnero, P., Johansen, J. S., Madsen, O. R., Tvede, N., Hansen, M. S., Thamsborg, G., Andersen, L. S., Majgaard, O., Loft, A. G., Erlendsson, J., Asmussen, K., Jurik, A. G., Moller, J., Hasselquist, M., Mikkelsen, D., Skjodt, T., Lambert, R., Hansen, A., and Østergaard, M. (2011) ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNF{alpha} inhibitors. Ann. Rheum. Dis. 70, 1375-1381
23. Pedersen, S. J., Chiowchanwisawakit, P., Lambert, R. G., Østergaard, M., and Maksymowych, W. P. (2011) Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation. J. Rheumatol. 38, 1349-1354
24. Tam, L. S., Gu, J., and Yu, D. (2010) Pathogenesis of ankylosing spondylitis. Nat. Rev. Rheumatol. 6, 399-405
25. Farach-Carson, M. C. (2001) Bioactive analogs that simulate subsets of biological activities of 1alpha,25(OH)(2)D(3) in osteoblasts. Steroids 66, 357-361
26. Wessel, D., and Flügge, U. I. (1984) A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 138, 141-143 (Pubitemid 14146660)
27. Fu, Q., Bovenkamp, D. E., and Van Eyk, J. E. (2007) A rapid, economical, and reproducible method for human serum delipidation and albumin and IgG removal for proteomic analysis. Methods Mol. Biol. 357, 365-371 (Pubitemid 350183261)
28. Smyth, G. K. (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3, Article3
29. Zhang, Y., Szustakowski, J., and Schinke, M. (2009) Bioinformatics analysis of microarray data. Methods Mol. Biol. 573, 259-284
30. Tibshirani, R. (1997) The lasso method for variable selection in the Cox model. Stat. Med. 16, 385-395
31. Smyth, G. K., Yang, Y. H., and Speed, T. (2003) Statistical issues in cDNA microarray data analysis. Methods Mol. Biol. 224, 111-136
32. Smith, C. A., O'Maille, G., Want, E. J., Qin, C., Trauger, S. A., Brandon, T. R., Custodio, D. E., Abagyan, R., and Siuzdak, G. (2005) METLIN: a metabolite mass spectral database. Ther. Drug Monit. 27, 747-751 (Pubitemid 44391729)
33. Ishizuka, S., Ishimoto, S., and Norman, A. W. (1984) Isolation and identification of 1 alpha,25-dihydroxy-24-oxovitamin D3, 1 alpha,25- dihydroxyvitamin D3 26,23-lactone, and 1 alpha,24(S),25-trihydroxyvitamin D3: in vivo metabolites of 1 alpha,25-dihydroxyvitamin D3. Biochemistry 23, 1473-1478 (Pubitemid 14137547)
34. Low, J. M., Chauhan, A. K., Gibson, D. S., Zhu, M., Chen, S., Rooney, M. E., Ombrello, M. J., and Moore, T. L. (2009) Proteomic analysis of circulating immune complexes in juvenile idiopathic arthritis reveals disease-associated proteins. Proteomics Clin. Appl. 3, 829-840
35. Zhuo, L., Kanamori, A., Kannagi, R., Itano, N., Wu, J., Hamaguchi, M., Ishiguro, N., and Kimata, K. (2006) SHAP potentiates the CD44-mediated leukocyte adhesion to the hyaluronan substratum. J. Biol. Chem. 281, 20303-20314 (Pubitemid 44065805)
36. Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., and Simon, J. C. (2002) Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195, 99-111 (Pubitemid 34074500)
37. Kida, D., Yoneda, M., Miyaura, S., Ishimaru, T., Yoshida, Y., Ito, T., Ishiguro, N., Iwata, H., and Kimata, K. (1999) The SHAP-HA complex in sera from patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 26, 1230-1238 (Pubitemid 29268070)
38. Yin, H., Gao, L., Shen, B., Chao, L., and Chao, J. (2010) Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation. Hypertension 56, 260-267
39. Wang, C. R., Chen, S. Y., Shiau, A. L., Wu, C. L., Jou, I. M., Chao, L., and Chao, J. (2007) Upregulation of kallistatin expression in rheumatoid joints. J. Rheumatol. 34, 2171-2176 (Pubitemid 350076875)
40. Pepys, M. B., Baltz, M., Gomer, K., Davies, A. J., and Doenhoff, M. (1979) Serum amyloid P-component is an acute-phase reactant in the mouse. Nature 278, 259-261 (Pubitemid 9129075)
41. Bijl, M., Bootsma, H., Van Der Geld, Y., Limburg, P. C., Kallenberg, C. G., and Van Rijswijk, M. H. (2004) Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction. Ann. Rheum. Dis. 63, 831-835 (Pubitemid 38850455)
42. Strachan, A. F., and Johnson, P. M. (1982) Protein SAP (serum amyloid P-component) in Waldenstrom's macroglobulinaemia, multiple myeloma and rheumatic diseases. J. Clin. Lab. Immunol. 8, 153-156 (Pubitemid 12022974)
43. Ishizuka, S., Ishimoto, S., and Norman, A. W. (1982) Isolation and identification of 25-hydroxyvitamin D3-26,23-peroxylactone. A novel in vivo metabolite of vitamin D3. J. Biol. Chem. 257, 14708-14713 (Pubitemid 13159564)
44. Miura, D., Manabe, K., Gao, Q., Norman, A. W., and Ishizuka, S. (1999) 1alpha,25-dihydroxyvitamin D(3)-26,23-lactone analogs antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells). FEBS Lett. 460, 297-302 (Pubitemid 29495958)
45. Tanaka, Y., DeLuca, H. F., Schnoes, H. K., Ikekawa, N., and Eguchi, T. (1981) 23,25-Dihydroxyvitamin D3: a natural precursor in the biosynthesis of 25-hydroxyvitamin D3-26,23-lactone. Proc. Natl. Acad. Sci. U.S.A. 78, 4805-4808 (Pubitemid 12225569)
46. Ikekawa, N. (1987) Structures and biological activities of vitamin D metabolites and their analogs. Med. Res. Rev. 7, 333-366
47. Chun, R. F., Lauridsen, A. L., Suon, L., Zella, L. A., Pike, J. W., Modlin, R. L., Martineau, A. R., Wilkinson, R. J., Adams, J., and Hewison, M. (2010) Vitamin D-binding protein directs monocyte responses to 25-hydroxy-and 1,25-dihydroxyvitamin D. J. Clin. Endocrinol. Metab. 95, 3368-3376
48. Adams, J. S., and Hewison, M. (2008) Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metab. 4, 80-90 (Pubitemid 351156900)
49. Lange, U., Teichmann, J., Strunk, J., Müller-Ladner, U., and Schmidt, K. L. (2005) Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos Int 16, 1999-2004 (Pubitemid 41790919)
50. Lange, U., Jung, O., Teichmann, J., and Neeck, G. (2001) Relationship between disease activity and serum levels of vitamin D metabolites and parathyroid hormone in ankylosing spondylitis. Osteoporos Int. 12, 1031-1035 (Pubitemid 34105974)
51. Polzer, K., Joosten, L., Gasser, J., Distler, J. H., Ruiz, G., Baum, W., Redlich, K., Bobacz, K., Smolen, J. S., van den Berg, W., Schett, G., and Zwerina, J. (2010) Interleukin-1 is essential for systemic inflammatory bone loss. Ann. Rheum. Dis. 69, 284-290
52. Gabay, C., and Kushner, I. (1999) Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454 (Pubitemid 29084777)
53. Whicher, J. T., Barnes, M. P., Brown, A., Cooper, M. J., Read, R., Walters, G., and Williamson, R. C. (1982) Complement activation and complement control proteins in acute pancreatitis. Gut 23, 944-950 (Pubitemid 12006900)
54. Osborn, T. M., Verdrengh, M., Stossel, T. P., Tarkowski, A., and Bokarewa, M. (2008) Decreased levels of the gelsolin plasma isoform in patients with rheumatoid arthritis. Arthritis Res. Ther 10, R117
55. Ayub, A., Mackness, M. I., Arrol, S., Mackness, B., Patel, J., and Durrington, P. N. (1999) Serum paraoxonase after myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 19, 330-335 (Pubitemid 29072747)
56. Séralini, G. E. (1991) A new role for corticosteroid binding globulin (CBG), member of SERPIN superfamily. C R Seances Soc Biol. Fil. 185, 500-509
57. Niessen, R. W., Lamping, R. J., Jansen, P. M., Prins, M. H., Peters, M., Taylor, F. B., Jr., de Vijlder, J. J., ten Cate, J. W., Hack, C. E., and Sturk, A. (1997) Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons. Thromb. Haemos. 78, 1088-1092 (Pubitemid 27417305)
58. Gangneux, C., Daveau, M., Hiron, M., Derambure, C., Papaconstantinou, J., and Salier, J. P. (2003) The inflammation-induced down-regulation of plasma Fetuin-A (alpha2HS-Glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sites. Nucleic Acids Res. 31, 5957-5970 (Pubitemid 37442322)
59. Chai, K. X., Chen, V. C., Ni, A., Lindpaintner, K., Rubattu, S., Chao, L., and Chao, J. (1997) Molecular cloning and expression of rat kallistatin gene. Biochim. Biophys. Acta 1353, 277-286 (Pubitemid 27439202)